Pay in 4 interest-free payments of $5.81 Learn more
Ships within 48 hours · Estimated delivery Oct 7 - Oct 12
Known side effects (class effects similar to other GLP-1 medications) Gastrointestinal issues (very common): Nausea: 38-43% of participants vs 11% placebo Diarrhea: 33-35% vs 13% placebo Vomiting: 20-21% vs 0% placebo Constipation: 22-25% vs 9% placebo Decreased appetite: 18-19% vs 9% placebo These are expected with incretin-based therapies and typically improve over time as your body adjusts
Once weekly exenatide: efficacy, tolerability and place in therapy
Saxenda: Best for those who dont have diabetes but need a reliable, long-term solution for weight loss
,aspect=ignore)
Targeting of the PI3K/AKT/GSK3 pathway in parkinson's disease: a therapeutic blueprint
What Happens When Aetna Says No
Virili C, et al
US$ 23.75
US$ 27.06
US$ 24.35
US$ 28.25
US$ 28.53
